Replies to post #1235 on Enanta Pharmaceuticals Inc (ENTA)

[NY1972]

The implication from Medivir’s PR is that JNJ’s HCV program, if not dead, is on life support. JNJ still has the HCV compounds acquired from ACHN, but without the Alios nuke [AL-704] it’s hard to see a viable business plan here.

Are AL-335 and AL-516 backups?